Detalhe da pesquisa
1.
Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
J Infect Dis
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626170
2.
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
HIV Med
; 25(2): 291-298, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816492
3.
Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne-Bonn region: a retrospective cohort study.
Infection
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492196
4.
HIV-Associated Microbial Translocation May Affect Cytokine Production of CD56bright NK Cells via Stimulation of Monocytes.
J Infect Dis
; 227(4): 577-582, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36520641
5.
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus-Positive Men Who Have Sex With Men (PROBE-C Study).
Clin Infect Dis
; 76(3): e607-e612, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004410
6.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Clin Infect Dis
; 76(5): 861-870, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259527
7.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Clin Infect Dis
; 77(7): 991-1009, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37207617
8.
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection.
J Hepatol
; 78(5): 947-957, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690280
9.
Why we need to re-define long-term success for people living with HIV.
HIV Med
; 24 Suppl 2: 3-7, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920411
10.
Long-term success for people living with HIV: A framework to guide practice.
HIV Med
; 24 Suppl 2: 8-19, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920412
11.
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
HIV Med
; 24(2): 224-230, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934954
12.
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
HIV Med
; 24(11): 1126-1136, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849432
13.
Hepatitis delta infection among persons living with HIV in Europe.
Liver Int
; 43(4): 819-828, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36625770
14.
Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.
Liver Int
; 43(7): 1427-1439, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37183550
15.
People living with HIV, HCV and HIV/HCV coinfection in intensive care in a German tertiary referral center 2014-2019.
Infection
; 51(6): 1645-1656, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055704
16.
The DoDo experience: an alternative antiretroviral 2-drug regimen of doravirine and dolutegravir.
Infection
; 51(6): 1823-1829, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526898
17.
Early combination therapy of COVID-19 in high-risk patients.
Infection
; 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38017344
18.
Circulating levels of endotrophin and cross-linked type III collagen reflect liver fibrosis in people with HIV.
BMC Infect Dis
; 23(1): 52, 2023 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36694115
19.
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After Vaccination.
J Infect Dis
; 225(10): 1688-1693, 2022 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323975
20.
Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral Therapy.
J Infect Dis
; 226(5): 901-906, 2022 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313340